Pretraga

Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1274544

Management of adults and children receiving CAR T- cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA)

Hayden, PJ; Roddie, C; Bader, P; Basak, GW; Bonig, H; Bonini, C; Chabannon, C; Ciceri, F; Corbacioglu, S; Ellard, R et al.
Management of adults and children receiving CAR T- cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA) // Annals of oncology, 33 (2022), 259-275 doi:10.1016/j.annonc.2021.12.003. Epub 2021 Dec 16. (međunarodna recenzija, članak, znanstveni)

CROSBI ID: 1274544 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Management of adults and children receiving CAR T- cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA)

Autori
Hayden, PJ ; Roddie, C ; Bader, P ; Basak, GW ; Bonig, H ; Bonini, C ; Chabannon, C ; Ciceri, F ; Corbacioglu, S ; Ellard, R ; Sanchez-Guijo, F ; Jäger, U ; Hildebrandt, M ; Hudecek, M ; Kersten, MJ ; Köhl, U ; Kuball, J ; Mielke, S ; Mohty, M ; Murray, J ; Nagler, A ; Rees, J ; Rioufol, C ; Saccardi, R ; Snowden, JA ; Styczynski, J ; Subklewe, M ; Thieblemont, C ; Topp, M ; Ispizua, ÁU ; Chen, D ; Vrhovac, Radovan ; Gribben, JG ; Kröger, N ; Einsele, H ; Yakoub-Agha, I

Izvornik
Annals of oncology (0923-7534) 33 (2022); 259-275

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
CAR T-cell therapy ; best practice recommendations

Sažetak
Background: Several commercial and academic autologous chimeric antigen receptor T-cell (CAR-T) products targeting CD19 have been approved in Europe for relapsed/refractory B-cell acute lymphoblastic leukemia, high-grade B-cell lymphoma and mantle cell lymphoma. Products for other diseases such as multiple myeloma and follicular lymphoma are likely to be approved by the European Medicines Agency in the near future. Design: The European Society for Blood and Marrow Transplantation (EBMT)-Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association collaborated to draft best practice recommendations based on the current literature to support health care professionals in delivering consistent, high-quality care in this rapidly moving field. Results: Thirty-six CAR-T experts (medical, nursing, pharmacy/laboratory) assembled to draft recommendations to cover all aspects of CAR-T patient care and supply chain management, from patient selection to long-term follow-up, post- authorisation safety surveillance and regulatory issues. Conclusions: We provide practical, clinically relevant recommendations on the use of these high- cost, logistically complex therapies for haematologists/oncologists, nurses and other stakeholders including pharmacists and health sector administrators involved in the delivery of CAR-T in the clinic. Keywords: B-cell acute lymphoblastic leukemia (B ALL) ; CAR T-cells ; cytokine release syndrome (CRS) ; immune effector cell associated neurotoxicity syndrome (ICANS) ; large B-cell lymphoma (LBCL) ; multiple myeloma (MM).

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA

Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb

Profili:

Avatar Url Radovan Vrhovac (autor)

Poveznice na cjeloviti tekst rada:

doi www.annalsofoncology.org

Citiraj ovu publikaciju:

Hayden, PJ; Roddie, C; Bader, P; Basak, GW; Bonig, H; Bonini, C; Chabannon, C; Ciceri, F; Corbacioglu, S; Ellard, R et al.
Management of adults and children receiving CAR T- cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA) // Annals of oncology, 33 (2022), 259-275 doi:10.1016/j.annonc.2021.12.003. Epub 2021 Dec 16. (međunarodna recenzija, članak, znanstveni)
Hayden, P., Roddie, C., Bader, P., Basak, G., Bonig, H., Bonini, C., Chabannon, C., Ciceri, F., Corbacioglu, S. & Ellard, R. (2022) Management of adults and children receiving CAR T- cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA). Annals of oncology, 33, 259-275 doi:10.1016/j.annonc.2021.12.003. Epub 2021 Dec 16..
@article{article, author = {Hayden, PJ and Roddie, C and Bader, P and Basak, GW and Bonig, H and Bonini, C and Chabannon, C and Ciceri, F and Corbacioglu, S and Ellard, R and Sanchez-Guijo, F and J\"{a}ger, U and Hildebrandt, M and Hudecek, M and Kersten, MJ and K\"{o}hl, U and Kuball, J and Mielke, S and Mohty, M and Murray, J and Nagler, A and Rees, J and Rioufol, C and Saccardi, R and Snowden, JA and Styczynski, J and Subklewe, M and Thieblemont, C and Topp, M and Ispizua, \'{A}U and Chen, D and Vrhovac, Radovan and Gribben, JG and Kr\"{o}ger, N and Einsele, H and Yakoub-Agha, I}, year = {2022}, pages = {259-275}, DOI = {10.1016/j.annonc.2021.12.003. Epub 2021 Dec 16.}, keywords = {CAR T-cell therapy, best practice recommendations}, journal = {Annals of oncology}, doi = {10.1016/j.annonc.2021.12.003. Epub 2021 Dec 16.}, volume = {33}, issn = {0923-7534}, title = {Management of adults and children receiving CAR T- cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA)}, keyword = {CAR T-cell therapy, best practice recommendations} }
@article{article, author = {Hayden, PJ and Roddie, C and Bader, P and Basak, GW and Bonig, H and Bonini, C and Chabannon, C and Ciceri, F and Corbacioglu, S and Ellard, R and Sanchez-Guijo, F and J\"{a}ger, U and Hildebrandt, M and Hudecek, M and Kersten, MJ and K\"{o}hl, U and Kuball, J and Mielke, S and Mohty, M and Murray, J and Nagler, A and Rees, J and Rioufol, C and Saccardi, R and Snowden, JA and Styczynski, J and Subklewe, M and Thieblemont, C and Topp, M and Ispizua, \'{A}U and Chen, D and Vrhovac, Radovan and Gribben, JG and Kr\"{o}ger, N and Einsele, H and Yakoub-Agha, I}, year = {2022}, pages = {259-275}, DOI = {10.1016/j.annonc.2021.12.003. Epub 2021 Dec 16.}, keywords = {CAR T-cell therapy, best practice recommendations}, journal = {Annals of oncology}, doi = {10.1016/j.annonc.2021.12.003. Epub 2021 Dec 16.}, volume = {33}, issn = {0923-7534}, title = {Management of adults and children receiving CAR T- cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA)}, keyword = {CAR T-cell therapy, best practice recommendations} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE

Citati:

    Altmetrijski pokazatelji:


    Podijeli:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font
    CROSBI koristi kolačiće (cookies) kako bi poboljšao funkcionalnost stranice.